Telemonitoring of CPAP Therapy in Apoplexy Patients With OSA

CPAP Therapie Mit Telemonitoring Bei Obstruktiver Schlafapnoe Und Apoplexie

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01986452

Enrollment

Registered

2013-11-18

Start date

2014-02-13

Completion date

2017-10-05

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

OSA, Apoplexy

Keywords

OSA, Apoplexy, CPAP, adherence, telemonitoring

Brief summary

Apoplexy patients with OSA are often not receiving a CPAP therapy due to generally poor acceptance and adherence. There is a great potential to significantly improve the treatment and care of these patients in a time economic way by telemonitoring the therapy in home environment. This study is planned to prove that telephone consultancy and motivation in times of recorded decreasing CPAP therapy usage can improve adherence, neurological function and quality of life.

Detailed description

Eligible patients with confirmed OSA from neurological rehab department of Helios Clinic Hagen Ambrock are asked to join the study. They will be randomly assigned to one of two arms \[CPAP with Telemonitoring (MTM) or without Telemonitoring (OTM)\] for 6 months of home treatment after hospital discharge. The MTM arm will receive supporting phone calls when the monitored usage time decreases.

Interventions

DEVICECPAP therapy

OTHERSupport

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

* s/p ACM (Arteria Cerebri Media Insult) * Diagnosed OSA AHI \>15/h * Barthel Index item 8 \> 5 points (or home assistance) * Life expectancy \>6 month * Capable of giving consent

Exclusion criteria

* Already existing ventilatory support (CPAP, NIV etc) * Central AI \>50% baseline * Central AI \>5/h under CPAP therapy * Drug abuse * Pregnant or nursing women * Participation in another clinical trial last 4 weeks

Design outcomes

Primary

Measure	Time frame	Description
Adherence to CPAP usage	6 months	CPAP device usage time will be readout and compared.

Secondary

Measure	Time frame	Description
Quality of life	6 months	Patients will fill the questionnaire SF-12 Health Survey before starting the therapy and after 6 months of therapy.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026